Infection Prevention, Business Continuity and Production Adjustments During COVID-19
First written in FY2021-Q1. 3 of 4 entries say "Restated". Latest entry: FY2022-Q2.
The whole theme swung hardest in 2024: 1 of 10 companies on the "Worse" side.
17 other companies' latest entry also says "Restated".
- FY2022-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, Japan's economy remained in an uncertain situation, despite signs of economic normalisation from the expanding rollout of vaccines, due to supply chain stagnation and the impact of COVID-19.」
This filing does not provide new details on specific infection-prevention measures or production adjustments, but reconfirms the business environment in which the pandemic and supply chain stagnation continue. - FY2021-Q3RestatedAnnual report
「Under these circumstances, the group continued its business activities after thoroughly implementing measures to prevent COVID-19 infections, while also carrying out flexible production adjustments and reducing nonessential and nonurgent expenses, but」
The company continues to implement COVID-19 infection-prevention measures, continue business activities, make flexible production adjustments and reduce nonessential and nonurgent expenses. - FY2021-Q2RestatedAnnual report
「Under these circumstances, the group continued its business activities after thoroughly implementing measures to prevent COVID-19 infections, while also carrying out flexible production adjustments and reducing nonessential and nonurgent expenses, but」
The company continues to implement COVID-19 infection-prevention measures, continue business activities, make flexible production adjustments and reduce nonessential and nonurgent expenses. - FY2021-Q1First statedAnnual report
「Under these circumstances, the group has continued its business activities after thoroughly implementing measures to prevent COVID-19 infections, while also making flexible production adjustments and reducing nonessential and nonurgent expenses.」
In response to the deterioration of the business environment caused by the spread of the pandemic, the company has for the first time presented in an integrated manner its infection-prevention measures, continuation of business activities, flexible production adjustments and reductions in nonessential and nonurgent expenses.